-
Study aim
-
Comparison of the effect of mannitol and hypertonic sodium administration to reduce ICP on hemodynamic parameters under LiDCO monitoring in patients under elective craniotomy
-
Design
-
This randomized clinical trial will be conducted in 1400-1401 at Sinai Hospital. In this study, adult patients aged 18 to 65 years with ASA status I and II who are to undergo elective craniotomy will be evaluated. Patients enrolled in the study will be randomly divided into two groups: mannitol (receiving 5 ml/kg mannitol 20%) or hypertonic sodium (receiving 3 mg/kg hypertonic serum 5%).
-
Settings and conduct
-
This randomized clinical trial will be performed in 1400 at Sina Hospital in the neurosurgery room by the anesthesia department in collaboration with the neurosurgery department. Patients admitted to the study will be randomly divided into mannitol or hypertonic sodium during craniotomy to control cerebrospinal fluid.
-
Participants/Inclusion and exclusion criteria
-
Adult patients aged 18 to 65 years with ASA status I and II undergoing elective craniotomy. exclude criteria: previous history of cranial surgery, pregnancy, obesity (BMI above 40), sodium level> 160 ,Hb <10, treated patients With hyperosmotic fluids 24 hours before surgery.
-
Intervention groups
-
Patients enrolled in the study will be randomly divided into two groups: mannitol (receiving 5 ml/kg mannitol 20%) or hypertonic sodium (receiving 3 mg/kg hypertonic serum 5%).
-
Main outcome variables
-
systolic blood pressure, diastolic blood pressure, MAP, PPV pulse pressure changes, SVV stroke volume changes, cardiac output CO, cardiac index CI, SV stroke volume, systemic vascular resistance SVR will be registered. Oxygenation recorded during monitoring based on PaO2, PaCO2, HCO3, pH, SaO2